Changes in platelet aggregation caused by glyburide in diabetic patients
- PMID: 6426797
Item in Clipboard
Changes in platelet aggregation caused by glyburide in diabetic patients
Clin Ther.
1984.
Abstract
The effect of glyburide on platelet aggregation was investigated in 31 patients with maturity-onset diabetes. Platelet aggregation in platelet-rich plasma was measured before and one hour after the patients had ingested 5 mg of glyburide. The drug caused a significant decrease in platelet aggregation as determined by changes in the amplitude and slope of the curve.
Similar articles
-
Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.Diabet Med. 2006 Feb;23(2):134-40. doi: 10.1111/j.1464-5491.2005.01765.x. Diabet Med. 2006. PMID: 16433710 Clinical Trial.
-
Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).Horm Metab Res Suppl. 1985;15:120-2. Horm Metab Res Suppl. 1985. PMID: 2934311 No abstract available.
-
Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide.J Lab Clin Med. 1993 Apr;121(4):555-61. J Lab Clin Med. 1993. PMID: 8454937
-
[Platelet aggregation].Rinsho Byori. 1987 Jun;Spec No 71:151-64. Rinsho Byori. 1987. PMID: 3306037 Review. Japanese. No abstract available.
-
[Platelet aggregation].Nihon Rinsho. 1995 Mar;53 Su Pt 2:141-6. Nihon Rinsho. 1995. PMID: 8753202 Review. Japanese. No abstract available.
Cited by
-
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease.Front Pharmacol. 2021 May 12;12:670155. doi: 10.3389/fphar.2021.670155. eCollection 2021. Front Pharmacol. 2021. PMID: 34054542 Free PMC article. Review.
-
Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.Med Toxicol. 1987 May-Jun;2(3):190-209. doi: 10.1007/BF03259864. Med Toxicol. 1987. PMID: 3298923 Review.
MeSH terms
Substances
LinkOut - more resources
Medical